251 related articles for article (PubMed ID: 14978342)
1. ATP- and adenosine-mediated signaling in the central nervous system: purinergic receptor complex: generating adenine nucleotide-sensitive adenosine receptors.
Yoshioka K; Nakata H
J Pharmacol Sci; 2004 Feb; 94(2):88-94. PubMed ID: 14978342
[TBL] [Abstract][Full Text] [Related]
2. Purinergic-receptor oligomerization: implications for neural functions in the central nervous system.
Nakata H; Yoshioka K; Kamiya T
Neurotox Res; 2004; 6(4):291-7. PubMed ID: 15545012
[TBL] [Abstract][Full Text] [Related]
3. Functions of heteromeric association between adenosine and P2Y receptors.
Nakata H; Yoshioka K; Kamiya T; Tsuga H; Oyanagi K
J Mol Neurosci; 2005; 26(2-3):233-8. PubMed ID: 16012196
[TBL] [Abstract][Full Text] [Related]
4. Purinergic signaling in Alzheimer's disease.
Erb L; Woods LT; Khalafalla MG; Weisman GA
Brain Res Bull; 2019 Sep; 151():25-37. PubMed ID: 30472151
[TBL] [Abstract][Full Text] [Related]
5. Agonists and Antagonists for Purinergic Receptors.
Müller CE; Baqi Y; Namasivayam V
Methods Mol Biol; 2020; 2041():45-64. PubMed ID: 31646479
[TBL] [Abstract][Full Text] [Related]
6. ATP- and adenosine-mediated signaling in the central nervous system: synaptic purinoceptors: the stage for ATP to play its "dual-role".
Kato F; Kawamura M; Shigetomi E; Tanaka J; Inoue K
J Pharmacol Sci; 2004 Feb; 94(2):107-11. PubMed ID: 14978346
[TBL] [Abstract][Full Text] [Related]
7. Heteromeric association creates a P2Y-like adenosine receptor.
Yoshioka K; Saitoh O; Nakata H
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7617-22. PubMed ID: 11390975
[TBL] [Abstract][Full Text] [Related]
8. ATP- and adenosine-mediated signaling in the central nervous system: adenosine receptor activation by ATP through rapid and localized generation of adenosine by ecto-nucleotidases.
Matsuoka I; Ohkubo S
J Pharmacol Sci; 2004 Feb; 94(2):95-9. PubMed ID: 14978343
[TBL] [Abstract][Full Text] [Related]
9. Regulation of pharmacology by hetero-oligomerization between A1 adenosine receptor and P2Y2 receptor.
Suzuki T; Namba K; Tsuga H; Nakata H
Biochem Biophys Res Commun; 2006 Dec; 351(2):559-65. PubMed ID: 17070771
[TBL] [Abstract][Full Text] [Related]
10. Dimerization of G protein-coupled purinergic receptors: increasing the diversity of purinergic receptor signal responses and receptor functions.
Nakata H; Suzuki T; Namba K; Oyanagi K
J Recept Signal Transduct Res; 2010 Oct; 30(5):337-46. PubMed ID: 20843271
[TBL] [Abstract][Full Text] [Related]
11. Purine nucleosides and nucleotides as central nervous system modulators. Adenosine as the prototypic paracrine neuroactive substance.
Williams M
Ann N Y Acad Sci; 1990; 603():93-107. PubMed ID: 1981308
[No Abstract] [Full Text] [Related]
12. Adenine nucleotides inhibit cytokine generation by human mast cells through a Gs-coupled receptor.
Feng C; Mery AG; Beller EM; Favot C; Boyce JA
J Immunol; 2004 Dec; 173(12):7539-47. PubMed ID: 15585881
[TBL] [Abstract][Full Text] [Related]
13. Solubilization of a guanine nucleotide-sensitive form of the P2Y-purinergic receptor.
Jeffs RA; Cooper CL; Harden TK
Mol Pharmacol; 1991 Jul; 40(1):85-92. PubMed ID: 1906978
[TBL] [Abstract][Full Text] [Related]
14. Irreversible activation of phospholipase C-coupled P2Y-purinergic receptors by 3'-O-(4-benzoyl)benzoyl adenosine 5'-triphosphate.
Boyer JL; Harden TK
Mol Pharmacol; 1989 Dec; 36(6):831-5. PubMed ID: 2689859
[TBL] [Abstract][Full Text] [Related]
15. Agonist-promoted heteromeric oligomerization between adenosine A(1) and P2Y(1) receptors in living cells.
Yoshioka K; Saitoh O; Nakata H
FEBS Lett; 2002 Jul; 523(1-3):147-51. PubMed ID: 12123822
[TBL] [Abstract][Full Text] [Related]
16. The importance of alkynyl chain presence for the activity of adenine nucleosides/nucleotides on purinergic receptors.
Dal Ben D; Buccioni M; Lambertucci C; Marucci G; Volpini R; Cristalli G
Curr Med Chem; 2011; 18(10):1444-63. PubMed ID: 21428896
[TBL] [Abstract][Full Text] [Related]
17. Identification of a P2Y-purinergic receptor that inhibits adenylyl cyclase.
Boyer JL; Lazarowski ER; Chen XH; Harden TK
J Pharmacol Exp Ther; 1993 Dec; 267(3):1140-6. PubMed ID: 8263774
[TBL] [Abstract][Full Text] [Related]
18. Biology of purinergic signalling: its ancient evolutionary roots, its omnipresence and its multiple functional significance.
Verkhratsky A; Burnstock G
Bioessays; 2014 Jul; 36(7):697-705. PubMed ID: 24782352
[TBL] [Abstract][Full Text] [Related]
19. Purinergic receptor regulation of signal transduction in NCB-20 cells.
Garritsen A; Zhang Y; Cooper DM
Mol Pharmacol; 1992 Apr; 41(4):743-9. PubMed ID: 1314945
[TBL] [Abstract][Full Text] [Related]
20. ATPgammaS enhances the production of inflammatory mediators by a human dermal endothelial cell line via purinergic receptor signaling.
Seiffert K; Ding W; Wagner JA; Granstein RD
J Invest Dermatol; 2006 May; 126(5):1017-27. PubMed ID: 16410784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
